• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Epigenetic and MicroRNA Biomarkers 2013 Market Report Product Image

Epigenetic and MicroRNA Biomarkers 2013 Market Report

  • Published: July 2013
  • 118 Pages
  • Select Biosciences Ltd

This market report from represents the most up-to-date analysis of the Epigenetic and MicroRNA Biomarkers spaces together with research market data [qualitative and quantitative analysis] characterizing the epigenetics and microRNA research fields.

The epigenetic and microRNA biomarkers fields are co-evolving and have reached a critical point wherein enough signatures have been identified across various different disease classes, most notably in cancer, that some of these signatures/expression patterns can be validated and deployed for use in the clinic. However, these biomarker fields are evolving in parallel with the research marketplace, and therefore the authors have in this market report characterized the research markets for both these fields so as to present a comprehensive analysis that en bloc provides a complete picture of this expanding marketplace.

Specific Topics Addressed in this Market Report:

Epigenetics Research Market Analysis

- Primary Market Survey to Characterize Research Market Trends based on Data Collected from Researchers
- Breakout of Epigenetics Research Activity based on Epigenetic Modifications Studied
- Segmentation of READ MORE >

Chapter I. Epigenetics Research Market Analysis

- Primary Market Survey to Characterize Marketplace from the Bottom-Up: Qualitative and Quantitative Market Data

- Current Research Paradigms

- Quantitative Segmentation of Epigenetics Research

- Epigenetics Research in Cancer: Quantitative Segmentation

- Commercial Kit and Reagent Offerings in the Epigenetics Research Marketplace

Chapter II. Epigenetic Signatures as Potential Biomarkers

- Big Data Analysis of Epigenetics Publication Landscape

- Hotspot Analysis of Publications Describes Segments of Opportunity vis-à-vis Research Product Development as well as Potential Assay Development for Disease Associations, Harvesting of Prognostic as well as Diagnostic Biomarkers

- Epigenetic Signatures Described in Various Disease Classes

- DNA Methylation as Disease Biomarkers

- Histone Modifications as Disease Biomarkers

- Potential Epigenetic Biomarkers in Various Cancer Classes

- Gastric Cancer

- Pancreatic Cancer

- Prostate Cancer

Chapter III. microRNA Research Market Analysis

- microRNA Signatures as Potential Biomarkers

- Primary Market Survey to Characterize Marketplace from the Bottom-Up: Qualitative and Quantitative Market Data

- microRNA Research vis-à-vis Content Classes

- microRNA Research in Cancer

- microRNA Research Workflow: Quantitative Breakout

- microRNA Expression Profiling Quantitative Market Breakout

- microRNA Vendor Market Penetration Space Map

- NGS to Study microRNAs—Market Breakout by Platform

- Unmet Needs in the microRNA Research Space

- microRNA Signatures Described in Various Disease Classes: Potential for Biomarker Development

- Tumor Suppressor microRNA Methylation

- microRNAs in Biofluids

- Circulating microRNAs as Potential Tumor Markers

Chapter IV. Characterization of Molecular Biomarker Classes

- Traditional Cancer Biomarkers

- Oncogenes

- Tumor Suppressor Genes

Appendix I. Epigenetic and MicroRNA Biomarker Summary

Appendix II. List of Companion Diagnostics (CDx) on the Market, In Progress CDx in Development/Partnerships, Potential Market Size for Epigenetic and microRNA-based CDx

Appendix III. Research Methodology

Note: Product cover images may vary from those shown


Our Clients

Our clients' logos